[Montreal, QC] Sell Your Science - Best Practices for Developing an Effective Non-Confidential Pitch DeckJLABS @ TorontoTuesday, April 24, 2018 from 10:00 AM to 1:00 PM (EDT) |
![[Montreal, QC] Sell Your Science - Best Practices for...](https://img.evbuc.com/https%3A%2F%2Fcdn.evbuc.com%2Fimages%2F42050006%2F150201790809%2F1%2Foriginal.jpg?h=150&w=300&auto=compress&rect=0%2C0%2C300%2C150&s=f24aae5951e92045f25badb4209b5e17)
|
Event Details
It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for sessions on learning the tricks of the trade in preparing a non-confidential deck and executive summary. Experts of the craft will share practical tips on becoming more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising.
Speaker:
Nicola Urbani | Investment Director, Emerillon Capital
A management and investment professional with a passion for innovation and broad experience (14 years) in venture capital investment in life sciences and cleantech industries. Worked in two different venture capital Fund managers with a total committed capital of over $400M: GeneChem management (with 4 different Funds targeting different stages and indications: GeneChem Technologies,GeneChem Therapeutics, AgeChem Financial, and AmorChem) and Emerillon Capital. Served on numerous Boards and helped shape company strategies, C-level management teams and Board committees. Active involvement in the growth of several companies developing therapeutics through human clinical trials, and participated in numerous financing rounds with top tier Canadian and international venture capital Funds. Led several in- and out-licensing deals in life sciences and cleantech. A focused, high-energy individual able to solve complex problems and achieve goals in challenging environments. Prior to joining Emerillon, Nicola was VP Commercialization at the McGill-affiliated Jewish General Hospital in Montreal, where he was responsible for technology transfer and the creation of companies. Nicola has a PhD in molecular genetics from McGill University and an MBA from Université du Québec à Montréal.
Connect with Nicola: 
Agenda:
10:00 AM | Registration
10:30 AM | Welcome & JLABS Presentation
11:00 AM | Sell Your Science Presentation
11:45 AM | Q&A
12:00 PM | Networking and Lunch
1:00 PM | Program Close
Who should attend:
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare start-ups in the pharma, medical device, consumer health and digital innovation areas.
Event Partner:
Fees:
$15 | General Public
Includes presentation, Q&A, and lunch.
Location:
1250 Guy St
Suite #600
Montreal, QC
H3H 2L3
When & Where
1250 Guy St
Suite 600
Montreal,
QC H3H 2L3
Canada
Tuesday, April 24, 2018 from 10:00 AM to 1:00 PM (EDT)
Add to my calendar
Organizer
JLABS @ Toronto
About Johnson & Johnson Innovation, JLABS
Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.
Share [Montreal, QC] Sell Your Science - Best Practices for Developing an Effective Non-Confidential Pitch Deck
Share Tweet